Back

The use of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in the prognosis of acute coronary syndromes

4 March 2019 (09:00 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 3 - Acute Coronary Syndromes – Pathophysiology and Mechanisms Inflammation ACVC Premium Access Acute Cardiovascular Care 2019

About the speaker

Photo
Doctor Maria Ines Pires

Hospital Sao Teotonio, Viseu (Portugal)

4 More presentations in this session

Presentation thumbnail
Doctor M. Del Buono (Rome, IT)
Abstract Slides
Presentation thumbnail
Doctor P. Eugenia (Rome, IT)
Abstract
Presentation thumbnail
Ms Y. Alekseeva (Tomsk, RU)
Abstract
Presentation thumbnail
Doctor A. Gombozhapova (Tomsk, RU)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 3 - Acute Coronary Syndromes – Pathophysiology and Mechanisms

The Event

Event poster

Acute Cardiovascular Care 2019

4 March 2019 09:00 CET
You may be interested in
thumbnail
Congress Presentation
The prognostic significance of the neutrophil-to-lymphocyte ratio in patients with acute decompensated heart failure
29 June 2021
thumbnail
Congress Presentation
Residual platelet activity and systemic inflammation in patients with chronic coronary syndrome in the context of aspirin monotherapy.
29 June 2021
thumbnail
Congress Presentation
Hemorrhagic risk scores: utillity predicting in-hospital mortality in acute coronary syndrome
21 May 2023
thumbnail
Congress Presentation
Platelet-large cell ratio predicts no-reflow in patients undergoing primary coronary angioplasty for ST-segment elevation myocardial infarction
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources